Last reviewed · How we verify
NCT03054467: SCARLET
Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina
Phase 4 trial testing Caduet 10Mg-20Mg Tablet in Quality of Life in 150 participants. Status unknown.
28 April 2019
Quick facts
| Lead sponsor | Kosin University Gospel Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 December 2018 |
| Primary completion | 28 April 2019 |
| Estimated completion | 28 April 2019 |
Drugs / interventions tested
- Caduet 10Mg-20Mg Tablet — full drug profile →
- NorvasC® 10 mg Tablets — full drug profile →
Conditions studied
- Quality of Life — all drugs for Quality of Life →
Sponsor
Kosin University Gospel Hospital
Who can join
Adults 18 to 70, any sex, with Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to compare the effects of CCB and CCB+ high dose of statin therapy on the symptoms, function, and quality of life assessed by validated angina-specific questionnaire (Short-form Seattle Angina Questionnaire (SAQ-7)), endothelial function as measured by FMD of the brachial artery, endothelial progenitor cells (EPC) and coronary flow reserve (CFR) in patients with VSA.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03054467
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Quality of Life
Currently open trials in the same condition.
- NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
- NCT07416448 — Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07412379 — Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer · recruiting
- NCT07380789 — Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07280416 — Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer · recruiting
Other Kosin University Gospel Hospital trials
Trials by the same sponsor.
- NCT03809780 — Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone · Phase 2 · unknown
- NCT03697356 — R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia · Phase 2 · recruiting
- NCT03760133 — The Change of Gut Microbiota After Bowel Preparation and the Effect of Probiotics · Phase 2 · completed
- NCT03153059 — Gut Microbiota and Stool Frequency · completed
- NCT03465527 — Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03054467 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kosin University Gospel Hospital
- Last refreshed: 10 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03054467.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing